BRCA1 and non-Hodgkin lymphoma: Additionally, 24.1% (7/29) reported atypical BRCA1/2 or Lynch presentation, including renal cell carcinoma, acute myeloid leukaemia, non-Hodgkin’s lymphoma, and gastrointestinal stromal tumour.